SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹19 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹6.07 Cr |
What is the latest Contingent Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹6.07 Cr |
| Mar2022 | ₹6.07 Cr |
| Mar2021 | ₹6.07 Cr |
How is Contingent Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 3.53 | |
| Mar2024 | ₹18 Cr | 198.50 | |
| Mar2023 | ₹6.07 Cr | 0.00 | |
| Mar2022 | ₹6.07 Cr | 0.00 | |
| Mar2021 | ₹6.07 Cr | - | |
Compare Contingent Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹12,038.5 Cr | -0.3% | -18.1% | -70.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -0.3% |
-18.1% |
-70.9% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses